Income Statement
BIOAFFINITY TECHNOLOGIES, INC.
BIAF
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
6.16 | 9.36 | 2.53 | 0.00 |
|
Cost of Revenue
|
- | - | - | 0.00 |
|
Gross Profit
|
6.16 | 9.36 | 2.53 | 0.00 |
|
Operating Expenses
|
16.73 | 18.32 | 10.51 | 4.02 |
|
Research & Development
|
1.38 | 1.46 | 1.50 | 1.14 |
|
Selling, General & Administrative
|
9.91 | 9.94 | 6.79 | 2.73 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-10.57 | -8.95 | -7.97 | -4.01 |
|
Non-Operating Income
|
-4.29 | -0.07 | 0.06 | 4.14 |
|
Interest Income
|
0.02 | 0.02 | 0.12 | 0.05 |
|
Interest Expense
|
- | - | 0.04 | 2.53 |
|
Other Non-Op Income / Expense
|
- | - | - | - |
|
Income Before Tax
|
-14.87 | -9.03 | -7.92 | -8.15 |
|
Income Tax Expense
|
0.04 | 0.01 | 0.02 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - |
|
Net Income
|
-14.91 | -9.04 | -7.94 | -8.15 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-10.07 | -8.35 | -7.72 | -4.00 |
|
Earnings Per Share (Basic)
|
-8.66 | -0.75 | -0.91 | -1.81 |
|
Diluted EPS
|
-8.66 | -0.75 | -0.91 | - |
|
Weighted Average Shares
|
1.72 | 12.13 | 8.75 | 4.50 |
|
Diluted Weighted Avg Shares
|
1.72 | 12.13 | 8.75 | - |
|
Comprehensive Income
|
- | - | - | - |